Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196

Watchlist Manager
Shanghai Fosun Pharmaceutical Group Co Ltd Logo
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Watchlist
Price: 27.14 CNY 0.3%
Market Cap: 69.4B CNY
Have any thoughts about
Shanghai Fosun Pharmaceutical Group Co Ltd?
Write Note

Shanghai Fosun Pharmaceutical Group Co Ltd
Short-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Shanghai Fosun Pharmaceutical Group Co Ltd
Short-Term Investments Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Short-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
Shanghai Fosun Pharmaceutical Group Co Ltd
SSE:600196
Short-Term Investments
ÂĄ6B
CAGR 3-Years
23%
CAGR 5-Years
60%
CAGR 10-Years
66%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Short-Term Investments
ÂĄ2.4B
CAGR 3-Years
-36%
CAGR 5-Years
-3%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Short-Term Investments
ÂĄ279.3m
CAGR 3-Years
2 201%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Short-Term Investments
ÂĄ973.2m
CAGR 3-Years
-38%
CAGR 5-Years
-33%
CAGR 10-Years
N/A
Yunnan Baiyao Group Co Ltd
SZSE:000538
Short-Term Investments
ÂĄ2.2B
CAGR 3-Years
-41%
CAGR 5-Years
-23%
CAGR 10-Years
15%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Short-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Short-Term Investments?
Short-Term Investments
6B CNY

Based on the financial report for Jun 30, 2024, Shanghai Fosun Pharmaceutical Group Co Ltd's Short-Term Investments amounts to 6B CNY.

What is Shanghai Fosun Pharmaceutical Group Co Ltd's Short-Term Investments growth rate?
Short-Term Investments CAGR 10Y
66%

Over the last year, the Short-Term Investments growth was 21%. The average annual Short-Term Investments growth rates for Shanghai Fosun Pharmaceutical Group Co Ltd have been 23% over the past three years , 60% over the past five years , and 66% over the past ten years .

Back to Top